Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

NeuroPace expects to use approximately $49.5 million of the net proceeds from the offering to repurchase 5,270,845 shares held by NeuroPace’s significant stockholder, KCK Ltd., at $9.40 per share, ...

The cybersecurity company returned to public markets Thursday in the first big U.S. technology listing of 2025.

NeuroPace expects to use a substantial portion of the proceeds from the public offering to repurchase all of the shares held by NeuroPace’s significant stockholder, KCK Ltd., at a price per share ...

SailPoint, Inc. (“SailPoint”), a leader in unified identity security for enterprises, today announced the pricing of its ...

announced today the closing of its underwritten initial public offering (the “Offering”) of 2,100,000 Class A Ordinary Shares at a public offering price of $4.00 per share, for total gross ...

The Bengaluru-based firm’s initial public offering, valued at ₹1,269 crore, is set to close on February 12. The firm has ...